Chimeric Antigen Receptor T-Cell Therapy in Aggressive B-Cell Lymphoma

被引：2
|
作者：
Hamilton, Mark P. [1 ,2 ,3 ]
Miklos, David B. [1 ,2 ]
机构：
[1] Stanford Univ, Sch Med, Stanford Canc Inst, Ctr Canc Cell Therapy, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Med, Div Blood & Marrow Transplantat & Cellular Therapy, Sch Med, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Dept Med, Div Hematol, Stanford, CA 94305 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 06期
关键词：
CAR T-cell; Large B-cell lymphoma; Aggressive lymphoma; CAR T-cell toxicity; CAR T-cell resistance; Review; CD19; NON-HODGKIN-LYMPHOMA; AXICABTAGENE CILOLEUCEL; DOSE-ESCALATION; OUTCOMES; RESPONSES; MULTICENTER; REMISSIONS; LEUKEMIA; IMPACT; TRIAL;
D O I：
10.1016/j.hoc.2023.05.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1053 / 1075
页数：23
相关论文
共 50 条
  • [21] Chimeric Antigen Receptor T Cells for B-Cell Lymphoma
    Newcomb, Richard
    Jacobson, Caron
    CANCER JOURNAL, 2021, 27 (02): : 107 - 111
  • [22] Chimeric antigen receptor copies in cell-free DNA predict relapse in aggressive B-cell lymphoma patients treated with CAR T-cell therapy
    de la Iglesia-San Sebastian, Ismael
    Lopez-Esteban, Miguel
    Bastos-Oreiro, Mariana
    de Cordoba-Onate, Sara Fernandez
    Gutierrez, Maravillas
    Carbonell, Diego
    Bailen, Rebeca
    Gomez-Centurion, Ignacio
    Fernandez-Caldas, Paula
    Castilla, Lucia
    Anguita, Javier
    Kwon, Mi
    Garcia-Sanz, Ramon
    Buno, Ismael
    Martinez-Laperche, Carolina
    BRITISH JOURNAL OF HAEMATOLOGY, 2025, 206 (01) : 195 - 203
  • [23] CD19 Chimeric Antigen Receptor Therapy for Refractory Aggressive B-Cell Lymphoma
    Jacobson, Caron A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04) : 328 - +
  • [24] FEASIBILITY, SAFETY, AND EFFICACY OF RADIATION THERAPY AS A BRIDGING STRATEGY FOR CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY FOR RELAPSED/REFRACTORY AGGRESSIVE B-CELL LYMPHOMA
    Laprade, Selena
    Babadagli, Ege
    Islam, Nabil
    Samant, Rajiv
    Kennah, Michael
    Kekre, Natasha
    Maltez, Melissa
    Tan, Sherry
    Nair, Vimoj
    RADIOTHERAPY AND ONCOLOGY, 2024, 198 : S48 - S48
  • [25] Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy
    Jallouk, Andrew P.
    Kui, Naishu
    Sun, Ryan
    Westin, Jason R.
    Steiner, Raphael E.
    Nair, Ranjit
    Nastoupil, Loretta J.
    Fayad, Luis E.
    Al Zaki, Ajlan
    Hawkins, Misha
    Adkins, Sherry
    Noorani, Mansoor
    Das, Kaberi
    Henderson, Jared
    Shpall, Elizabeth J.
    Kebriaei, Partow
    Ramdial, Jeremy
    Flowers, Christopher R.
    Neelapu, Sattva S.
    Ahmed, Sairah
    Strati, Paolo
    HAEMATOLOGICA, 2024, 109 (05) : 1460 - 1468
  • [26] Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy
    Iacoboni, Gloria
    Iraola-Truchuelo, Josu
    O'Reilly, Maeve
    Navarro, Victor
    Menne, Tobias
    Kwon, Mi
    Martin-Lopez, Ana africa
    Chaganti, Sridhar
    Delgado, Javier
    Roddie, Claire
    Perez, Ariadna
    Norman, Jane
    Guerreiro, Manuel
    Gibb, Adam
    Caballero, Ana Carolina
    Besley, Caroline
    Martinez-Cibrian, Nuria
    Mussetti, Alberto
    Sanderson, Robin
    Luzardo, Hugo
    Iyengar, Sunil
    Sanchez, Jose Maria
    Jones, Ceri
    Sancho, Juan-Manuel
    Barba, Pere
    Latif, Anne-Louise
    Lopez-Corral, Lucia
    Hernani, Rafael
    Reguera, Juan Luis
    Sureda, Anna
    Garcia-Sancho, Alejandro Martin
    Bastos, Mariana
    Abrisqueta, Pau
    Kuhnl, Andrea
    HEMASPHERE, 2024, 8 (05):
  • [27] Chimeric antigen receptor T-cell therapy for the treatment of aggressive B-cell non-Hodgkin lymphomas: efficacy, toxicity, and comparative chimeric antigen receptor products
    Hunter, Bradley D.
    Rogalski, Michael
    Jacobson, Caron A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (11) : 1157 - 1164
  • [28] Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma
    Nath, Karthik
    Tomas, Ana Alarcon
    Flynn, Jessica
    Fein, Joshua A.
    Alperovich, Anna
    Anagnostou, Theodora
    Batlevi, Connie Lee
    Dahi, Parastoo B.
    Fingrut, Warren B.
    Giralt, Sergio A.
    Lin, Richard J.
    Palomba, M. Lia
    Peled, Jonathan U.
    Salles, Gilles
    Sauter, Craig S.
    Scordo, Michael
    Fraint, Ellen
    Feuer, Elise
    Shah, Nishi
    Slingerland, John B.
    Devlin, Sean
    Shah, Gunjan L.
    Gupta, Gaurav
    Perales, Miguel-Angel
    Shouval, Roni
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (11): : 751.e1 - 751.e7
  • [29] Current perspectives on resistance to chimeric antigen receptor T-cell therapy and strategies to improve efficacy in B-cell lymphoma
    Ong, Shin Yeu
    Chen, Yunxin
    Tan, Melinda Si Yun
    Ho, Aloysius Yew Leng
    Hwang, William Ying Khee
    Lim, Francesca Lorraine Wei Inng
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (02) : 144 - 152
  • [30] Chimeric Antigen Receptor T-Cell Therapy for Companion Canines with Spontaneous B-Cell Non-Hodgkin Lymphoma
    O'Connor, Colleen M.
    Olivares, Simon
    Ang, Sonny
    Champlin, Richard E.
    Wilson-Robles, Heather M.
    Cooper, Laurence J. N.
    MOLECULAR THERAPY, 2013, 21 : S249 - S249
12345